Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Jun 16;10(6):e036587.
doi: 10.1136/bmjopen-2019-036587.

Effectiveness of cervical pessary compared to cervical cerclage with or without vaginal progesterone for the prevention of preterm birth in women with twin pregnancies and a short cervix: study protocol for a two-by-two factorial randomised clinical trial

Vinh Q Dang  1   2 , Yen Tn He  2   3 , Ha Nh Pham  4 , Tuyen Tt Trieu  3 , Trung Q Bui  4 , Nhu T Vuong  4 , Loc Mt Nguyen  2 , Diem Tn Nguyen  2 , Thanh V Le  4 , Wentao Li  5 , Cam H Le  3 , Ben W Mol  5 , Lan N Vuong  6
Affiliations

Effectiveness of cervical pessary compared to cervical cerclage with or without vaginal progesterone for the prevention of preterm birth in women with twin pregnancies and a short cervix: study protocol for a two-by-two factorial randomised clinical trial

Vinh Q Dang et al. BMJ Open. .

Abstract

Introduction: Women with twin pregnancies and a short cervix are at increased risk for preterm birth (PTB). Given the burden of prematurity and its attendant risks, the quest for effective interventions in twins has been an area of considerable research. Studies investigating the effectiveness of cervical cerclage, cervical pessary and vaginal progesterone in preventing PTB have yielded conflicting results. The aim of this study is to compare the effectiveness of cervical pessary and cervical cerclage with or without vaginal progesterone to prevent PTB in women with twin pregnancies and a cervical length (CL) ≤ 28 mm.

Methods and analysis: This multicentre, randomised clinical trial will be conducted at My Duc Hospital and My Duc Phu Nhuan Hospital, Vietnam. Asymptomatic women with twin pregnancies and a CL ≤28 mm, measured at 16-22 weeks' gestation, will be randomised in a 1:1:1:1 ratio to receive a cerclage, pessary, cerclage plus progesterone or pessary plus progesterone. Primary outcome will be PTB <34 weeks. Secondary outcomes will be maternal and neonatal complications. We preplanned a subgroup analysis according to CL from all women after randomisation and divided into four quartiles. Analysis will be conducted on an intention-to-treat basis. The rate of PTB <34 weeks' gestation in women with twin pregnancies and a cervix ≤28 mm and treated with pessary in our previous study at My Duc Hospital was 24.2%. A sample size of 340 women will be required to show or refute that cervical cerclage decreases the rate of PTB <34 weeks by 50% compared with pessary (from 24.2% to 12.1%, α level 0.05, power 80%, 5% lost to follow-up and protocol deviation). This study is not to be powered to assess interactions between interventions.

Ethics and dissemination: Ethical approval was obtained from the Institutional Ethics Committee of My Duc Hospital and informed patient consent was obtained before study enrolment. Results of the study will be submitted for publication in a peer-reviewed journal.

Trial registration number: NCT03863613 (date of registration: 4 March 2019).

Keywords: fetal medicine; maternal medicine; ultrasonography.

PubMed Disclaimer

Conflict of interest statement

Competing interests: VQD has received grant from Merck Sharpe and Dohme. BWM reports support from a NHMRC Practitioner Fellowship (GNT1082548) and consultancy for ObsEva, Merck and Guerbet. LNV has received speaker and conference fees from Merck, grant, speaker and conference fees from Merck Sharpe and Dohme, and speaker, conference and scientific board fees from Ferring.

Figures

Figure 1
Figure 1
Flow of participants.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Saigal S, Doyle LW. An overview of mortality and sequelae of preterm birth from infancy to adulthood. Lancet 2008;371:261–9. 10.1016/S0140-6736(08)60136-1 - DOI - PubMed
    1. Statistics OfN Gestation-specific infant mortality: 2012, 2014. Available: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/...
    1. Blencowe H, Krasevec J, de Onis M, et al. . National, regional, and worldwide estimates of low birthweight in 2015, with trends from 2000: a systematic analysis. Lancet Glob Health 2019;7:e849–60. 10.1016/S2214-109X(18)30565-5 - DOI - PMC - PubMed
    1. Liu L, Oza S, Hogan D, et al. . Global, regional, and national causes of child mortality in 2000-13, with projections to inform post-2015 priorities: an updated systematic analysis. Lancet 2015;385:430–40. 10.1016/S0140-6736(14)61698-6 - DOI - PubMed
    1. Allotey J, Zamora J, Cheong-See F, et al. . Cognitive, motor, behavioural and academic performances of children born preterm: a meta-analysis and systematic review involving 64 061 children. BJOG 2018;125:16–25. 10.1111/1471-0528.14832 - DOI - PubMed

Publication types

Associated data